Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Re reimbursement for Beating the Blues

30th Mar 2010 07:00

RNS Number : 3601J
Ultrasis PLC
30 March 2010
 

Ultrasis plc

 

BEATING THE BLUES APPROVED FOR REIMBURSEMENT IN THE NETHERLANDS

 

 

Ultrasis plc, the provider of interactive healthcare and associated services, is pleased to announce that from April 1st 2010 Dutch health insurance companies have approved Beating the Blues as a reimbursable treatment for depression within basic health insurance cover in the Netherlands.

 

Our exclusive partners in the Netherlands, Innohealth B.V., are pioneering the delivery of Beating the Blues through their network of therapists and believe that this form of treatment will both increase access and provide a more cost effective model of treatment. The model to be used involves the delivery of Beating the Blues by therapists, who will continue to remotely monitor progress and manage the care of patients.

 

Ends

 

Editors Notes:

Ultrasis plc is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and internationally. 

Beating the Blues is an eight-week, web-based treatment programme for mild and moderate depression based on Cognitive Behavioural Therapy. Following a rigorous examination by the National Institute for Health and Clinical Excellence (NICE), Beating the Blues was approved by NICE in February 2006 for use in the National Health Service. 

www.ultrasis.com

Contact details:

 

Ultrasis plc

Nigel Brabbins CEO etc

 

Innohealth B.V.

Contact: Arjan van der Weijde - Director

Tel: 088 0104333

E-mail: [email protected]

 

Ultrasis

Contact: Karen White/Sarah Rice

Tel: +44 117 9073400

[email protected] [email protected]

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAJLMITMBJTBJM

Related Shares:

Ultrasis Plc
FTSE 100 Latest
Value8,275.66
Change0.00